SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-13-003849
Filing Date
2013-10-17
Accepted
2013-10-17 16:58:21
Documents
1
Period of Report
2013-10-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT q13johnsonf4.html 4  
1 OWNERSHIP DOCUMENT q13johnsonf4.xml 4 4192
  Complete submission text file 0001387131-13-003849.txt   5694
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 131157027